Podchaser Logo
Home
SUMIT: Selumetinib in metastatic uveal melanoma (with Paul Nathan)

SUMIT: Selumetinib in metastatic uveal melanoma (with Paul Nathan)

Released Monday, 24th June 2019
Good episode? Give it some love!
SUMIT: Selumetinib in metastatic uveal melanoma (with Paul Nathan)

SUMIT: Selumetinib in metastatic uveal melanoma (with Paul Nathan)

SUMIT: Selumetinib in metastatic uveal melanoma (with Paul Nathan)

SUMIT: Selumetinib in metastatic uveal melanoma (with Paul Nathan)

Monday, 24th June 2019
Good episode? Give it some love!
Rate Episode

Unlock Episode Insights with

Podchaser Logo PRO

Reach • Demographics • Contacts • More

Pro Features

Audience & Reach for SUMIT: Selumetinib in metastatic uveal melanoma (with Paul Nathan)

See a breakdown of Audience & Reach for SUMIT: Selumetinib in metastatic uveal melanoma (with Paul Nathan)

Unlock Episode Audience & Reach with Podchaser Pro

Brand Safety for SUMIT: Selumetinib in metastatic uveal melanoma (with Paul Nathan)

See Brand Safety for SUMIT: Selumetinib in metastatic uveal melanoma (with Paul Nathan)

Unlock Episode Brand Safety with Podchaser Pro

Ad Rate Card of Medicine Matters oncology

How much does it cost to advertise on Medicine Matters oncology?

PlacementCost
Pre-rollAds played before an episode.
Mid-rollAds played during an episode.
Post-rollAds played after an episode.

Frequently Asked Questions about Medicine Matters oncology

Rate

Join Podchaser to...

  • Rate podcasts and episodes
  • Follow podcasts and creators
  • Create podcast and episode lists
  • & much more

Episode Tags

Do you host or manage this podcast?
Claim and edit this page to your liking.
,

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features